[}0Z}E}0+_ l,``s|n

*66v00 bx~p?+1xp s#p`cpp#)wp z?Y u; F{=J6{-=F1{-p 0)n0f_w Y^v y9}}z $|D[ KtNB} QTXTLK5C !@Rjv3 Hv rH~}@DYD#H. 

Chapters L2@`uNtz FF]5F
A multidisciplinary panel review the latest developments in R/R CLL and indolent lymphomas and share expert overviews of clinical trial interpretation and best practice in patient communication.
GHX~,
)Q /-S SlS}
e66
%`
=Ac}I
Chapters TYqS@BNw cViV&idd
An expert multidisciplinary panel review the latest developments in CLL and the evolving role of BTK inhibitors via an interactive agenda including presentations, ‘Ask the Experts’ sessions and workshops.
GHX~,
6n ;9n \m\6
e66
n)]g
es{
Chapters WZ2vV}i= `2NWHNst
Chaired by Ramón García-Sanz, our expert faculty review the topic of Waldenström’s macroglobulinemia and the role of BTK inhibitors via an exciting program of presentations, patient case studies, interactive workshops and Q&A sessions.
GHX~,
zA U%a 1&11
!A
n)]g
/1Y

Please login or register for full access

Register

Already registered?  Login